Nippon India Pharma Fund - Direct Plan - Growth Plan

Very High Risk
Equity
Sector - Healthcare

NAV as on Aug 25, 2026

Price per unit of the scheme.

₹ 644.58440.45%1 Day Change

3.13%

Minimum Investment₹5000

Expense Ratio1.03%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

*Morningstar Rating Methodology i

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions

FUND PERFORMANCE

As On Jan 01, 2023

Compare fund’s performance against category average across different time periods

No Data Found.

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

FUND COMPARISON

1M 3M 6M 1Y 3Y 5Y

This Fund

Nippon India Pharma Fund - Direct Plan - Growth Plan

Equity: Sector - Healthcare Average NAV

Topper in Equity: Sector - Healthcare

All Fund

No Data Found.

*For the other fund, rescaled NAVs are used

RETURN CALCULATOR

Check the return on your investment in the fund

Nippon India Pharma Fund - Direct Plan - Growth Plan

Investment Type

Monthly Investment

Time Period (yrs)

Annual Return in %

Invested Amount
₹0
Return
₹0

Current Value
₹0

FUND SUMMARY

Benchmark

S&P BSE Healthcare TR INR

Expense Ratio

1.03%

Category Avg Expense Ratio

1.01%

Minimum Investment (Lumpsum/SIP)

₹ 5000 /₹ 100

Lock In (Years)

No Lock-in

Fund Size

₹ 9,279.11 Cr(As on Jul, 2026)

Inception Date

Jan 01, 2013

Turnover

21.00 %

Exit Load

1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units. Nil, thereafter.

Objective: The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund - Direct Plan - Growth Plan is an Equity - Sector - Healthcare fund. The fund was launched inJan 01, 2013. Its risk level is . The NAV of the fund as onAug 25, 2026 is ₹644.58. Its expense ratio is 1.03 %. The fund has an AUM of ₹9,279.11 Cr.The fund is managed bySailesh Raj Bhan,Akshay Sharma,Kinjal Desai,Lokesh Maru,Divya Sharma,Amber Singhania.
The minimum initial investment is ₹5000 in Lumpsum mode.

SUBSCRIBE TO

BUSINESS TODAY MAGAZINE

Subscribe Now

Already a subscriber?Login

DETAILED PORTFOLIO

As on Jul, 2026

EQUITY (97.32%)

DEBT (-%)

CASH (2.68%)

Allocation by Market Cap

Large Cap(31.15%)

Mid Cap(38.58%)

Small Cap(27.58%)

Industry Holdings

Drug Manufacturers Specialty Generic63.12%
Diagnostics Research13.48%
Medical Care11.94%
Drug Manufacturers Major6.63%
Pharmaceutical Retailers New2.77%
Biotechnology2.07%

Stock Holdings

Sun Pharmaceuticals Industries Ltd13.31%
Lupin Ltd7.25%
Divi's Laboratories Ltd6.52%
Cipla Ltd6.03%
Apollo Hospitals Enterprise Ltd5.30%
Dr Reddy's Laboratories Ltd5.01%

PERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.

Consistency
i
It represents the consistency of a fund in beating its benchmark.
Downside Risk
i
Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
Risk Adjusted Return
i
Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
Volatility
i
Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
Upside Capture Ratio
i
Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
Downside Capture Ratio
i
Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

PEER ANALYSIS

card
table

Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

TOP FUNDS FROM THIS AMC

card
table

Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

ABOUT THE AMC

Nippon Life India Asset Management Ltd

Nippon Life India Asset Management Ltd manages assets worth ₹ 8,01,431.28 crores. It’s current offering of mutual fund schemes includes 34 equity, 80 debt and 14 hybrid schemes.

Phone

022-6808 7000/18602660111

customercare@nipponindiaim.in

AUM

₹ 8,01,431.28 Cr (

As on Jul 31, 2026

)

Address

4th Floor, Tower A, Peninsula Business Park, Mumbai,400 013

FAQs

What is the category of Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The category of Nippon India Pharma Fund - Direct Plan - Growth Plan is Equity - Sector - Healthcare

What is the current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan as on Aug 25, 2026 is ₹644.58

How safe is Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The risk level of Nippon India Pharma Fund - Direct Plan - Growth Plan is Very High.

What are short term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in 1 month is 3.13%, 3 months is 6.02%, 6 months is 11.61%, and 1 year is 10.65%

What are the long term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in 3 years is 19.47% and 5 years is 14.50%.

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan is 1.03%

What is the AUM of Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The assets under Management (AUM) of Nippon India Pharma Fund - Direct Plan - Growth Plan is Rs 9,279.11 crores.

What is the minimum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan ?

The minimum Lumpsum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is ₹5,000.00 and the minimum SIP investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is ₹100.00

What is the asset allocation of Nippon India Pharma Fund - Direct Plan - Growth Plan?

Nippon India Pharma Fund - Direct Plan - Growth Plan has an exposure of 97.32% in Equity and 2.68% in Cash & Money Market Securities